Vaxxinity

Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
BioSpace
Thu, 02/15/24 - 11:40 am
Vaxxinity
VXX-401
vaccines
cholesterol
New research collaboration tackles medical challenges of space flight
Biopharma Reporter
Mon, 01/22/24 - 11:17 am
Vaxxinity
R&D
space flight
Vaxxinity Alzheimer’s treatment shows promising results in early trial
Biopharma Reporter
Tue, 08/15/23 - 10:07 am
Vaxxinity
clinical trials
UB-311
Alzheimer's disease
Vaxxinity celebrates trial success in early Parkinson’s therapy
Clinical Trials Arena
Fri, 06/23/23 - 09:42 am
Vaxxinity
clinical trials
vaccines
Parkinson's Disease
UB-312
Help wanted: Vaxxinity seeks a partner to press ahead with Alzheimer's treatment
Fierce Biotech
Tue, 03/28/23 - 10:11 am
Vaxxinity
Alzheimer's disease
clinical trials
UB-311
Vaxxinity’s Phase III Covid-19 booster trial meets endpoints
Clinical Trials Arena
Mon, 12/5/22 - 10:50 am
Vaxxinity
UB-612
clinical trials
COVID-19
vaccines
Vaxxinity concludes subject enrolment in Phase III Covid-19 vaccine trial
Clinical Trials Arena
Tue, 10/25/22 - 10:39 am
Vaxxinity
clinical trials
UB-612
vaccines
COVID-19
Life Sciences Industry has Eyes on Texas' Innovation Corridor
BioSpace
Wed, 05/4/22 - 10:45 am
Texas
biotech hubs
life sciences
Fujifilm
BioBridge
Luminex
Vaxxinity
Veravas
Cassava Sciences
Biotech Companies Launch or Plan IPOs: Vaxxinity, Genenta and Enetrada
BioSpace
Thu, 11/11/21 - 11:26 pm
IPOs
Vaxxinity
Genenta Science
Enetrada
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Fierce Biotech
Thu, 11/11/21 - 11:03 am
Vaxxinity
IPOs
vaccines
immunotherapy
NASDAQ
IPO floodgates open up after summer lull as five more biotechs file for Nasdaq
Endpoints
Tue, 10/12/21 - 10:59 am
Evotec
Entrada Therapeutics
Aura Biosciences
Vaxxinity
Blue Water Vaccines
IPOs